Description
| Description | Radezolid is a novel oxazolidinone antibiotic agent. |
| In vitro | Radezolid displays a greater potency than linezolid, independent of the bacteria tested, when concentrations are expressed on a weight (mg/L) basis. Radezolid shows an improved potency compared to that of linezolid when concentrations are expressed on a weight (mg/L) basis. Radezolid MICs are systematically equal to or lower (up to 3 log2 dilutions) compared to those of linezolid for all linezolid-susceptible strains, with an 8-fold difference for the linezolid-resistant strains. Radezolid and TR-700 perform well against 3-copy G2447T, G2576T, and G2576T/T2571C mutants [1][2]. |
| Synonyms | RX-1741 |
| Molecular Weight |
438.45 |
| Formula | C22H23FN6O3 |
| CAS No. | 869884-78-6 |
Storage
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Solubility Information
DMSO: 25 mg/mL (57.02 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
